Shares of HealthEquity (HQY) are soaring 5.66% in Wednesday's trading session following the company's impressive second-quarter fiscal 2026 results and upward revision of full-year guidance. The leading provider of Health Savings Account (HSA) custodial services in the United States continues to demonstrate robust financial performance and strategic growth.

HealthEquity reported a 9% year-over-year increase in revenue, reaching $325.8 million for Q2. More notably, the company's net income jumped by 67% to $59.9 million, while adjusted earnings per share came in at $1.08, marking a 26% increase from the previous year. The strong financial results were driven by solid asset growth, cost improvements, and a strategic focus on digital adoption and security measures.

Following these strong results, HealthEquity's management raised its full-year guidance for fiscal 2026. The company now projects revenue between $1.290 billion and $1.310 billion, with adjusted EBITDA expected to range from $540 million to $560 million. This optimistic outlook has further fueled investor confidence in the stock. Analysts have responded positively to HealthEquity's performance, with several firms maintaining their buy ratings and raising price targets, reflecting the market's bullish sentiment on the company's growth prospects.